# Efficacy and Safety of Renalof® in the Removal of Calculi Smaller Than 10 mm Located in the Reno-Ureteral Tract

> **NCT04695951** · PHASE2 · COMPLETED · sponsor: **Catalysis SL** · enrollment: 155 (actual)

## Conditions studied

- Renal Injury
- Kidney Injury
- Kidney Calculi
- Ureteral Obstruction
- Ureteral Calculi
- Renal Stone
- Ureteral Injury
- Renal Disease
- Urolithiasis, Calcium Oxalate
- Urolithiasis; Lower Urinary Tract
- Urolithiasis

## Interventions

- **DIETARY_SUPPLEMENT:** Renalof
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT04695951
- **Lead sponsor:** Catalysis SL
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-08-01
- **Primary completion:** 2020-07-01
- **Final completion:** 2020-10-01
- **Target enrollment:** 155 (ACTUAL)
- **Last updated:** 2021-01-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04695951

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04695951, "Efficacy and Safety of Renalof® in the Removal of Calculi Smaller Than 10 mm Located in the Reno-Ureteral Tract". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT04695951. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*